Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia

Keyphrases

• Thrombosis 100%
• Heparin-induced Thrombocytopenia 100%
• Argatroban 100%
• Anticoagulant Therapy 100%
• Control Subjects 66%
• Thrombocytopenia 33%
• Historical Controls 22%
• Activated Partial Thromboplastin Time (aPTT) 22%
• Clinical Outcomes 22%
• Immune Response 11%
• All-cause Mortality 11%
• Anticoagulation 11%
• Amputation 11%
• Between-group 11%
• Heparin 11%
• Platelet Count 11%
• Composite Endpoint 11%
• Between-group Difference 11%
• Temporal Baseline 11%
• Bleeding Events 11%
• Rapid Rise 11%
• Time-to-event Analysis 11%
• Direct Thrombin Inhibitors 11%
• Bleeding Risk 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Argatroban 100%
• Anticoagulant Agent 100%
• Heparin Induced Thrombocytopenia 100%
• Thrombosis 100%
• Syndrome 66%
• Thrombocytopenia 33%
• Thromboplastin 22%
• 5 Nitro 2 (3 Phenylpropylamino)benzoic Acid 11%
• Thrombin Inhibitor 11%
• Heparin 11%